• Victoria Gosalbes Soler, Alvaro Bonet Plá, Carlos Sanchis Doménech, Antonio Fornos Garrigós, Carlos Fluixá Carrascosa, Asunción Ajenjo Navarro, and Investigators of the Grupo de Cardiovascular de la Sociedad Valenciana de Medicina Familiar y Comunitaria.
• Medicina de Familia, Centro de Salud de Salvador Pau, Valencia, España. gosalbes@comv.es
• Aten Primaria. 2007 Oct 1; 39 (10): 557563557-63.

ObjectiveTo evaluate a primary care protocol for intensive monitoring of cardiovascular risk (CVR) factors in type-2 diabetes patients versus usual care.DesignRandomised trial with clusters.SettingPrimary care clinics.ParticipantsSixty family physicians.InterventionsParticipants were randomised between following a protocol of intensive monitoring of CVR factors and maintaining their habitual practice with DM2 patients. Follow-up lasted 12 months. Data on HbA1C, CVR factors and CVR were collected at the start of the study and at 12 months.ResultsIn all, 188 patients (94 intervention group and 94 control group) were included. At baseline measurement, CVR in control group (CG) was 36.3% (95% CI, 33.9%-38.6%); and in intervention group (IG), 35.9% (95% CI, 33.5%-38.4%), with no significant differences between groups. At one year, CVR in CG was 33.1% (95% CI, 30%-36.1%) and in IG 30.5% (95% CI, 27.8%-33.2%). The CVR difference between baseline and 1-year measurements was 2.9% (95% CI, 0.2%-5.7%) in CG and 5.4% (95% CI, 2.8%-7.1%) in IG.ConclusionsAlthough improvement of CVR is greater in the IG, the difference between the two groups is not significant. The characteristics of the doctors chosen may have meant that the patients of the two groups received similar treatment.

11 keywords...

hide…